Список публикаций на английском языке

  1.  C. Delaugerre,  G.Antoni,  N.Mahjoub,  G.Pialoux et al, Assessment of HIV Screening Tests for Use in Preexposure Prophylaxis Programs, Journal of Infectious Diseases,  2017 216(3) 382-386

  2. C. Ottiger and A. R. Huber, Comparison o the New Alere HIV Combo with Alere Determine HIV-1/2 Ag/Ab Combo in Acute Primo, Annals of Clinical and Laboratory Research, 2015, Vol. 3 No. 3:22

  3. Shanks L., Siddiqui M., Kliescikova J., Pearce N., Ariti C., Muluneh L., Pirou E., Ritmeijer K., Masiga J., Abebe A. Evaluation of HIV testing algorithms in Ethiopia: the role of the tie-breaker algorithm and weakly reacting test lines in contributing to a high rate of false positive HIV diagnoses. BMC Infectious Diseases, 2015, v. 15, 3 February, Page 1-10.

  4. Gautheret-Dejean A., Bocobza J.,  Brunet S., Damond F., Plantier J.C., Barin F. Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections. Journal of Medical Virology, 2015, Vol. 87 Issue 9.

  5. Duong YT, Mavengere Y, Patel H, et al. Poor performance of the determine HIV-1/2 Ag/Ab combo fourth-generation rapid test for detection of acute infections in a National Household Survey in Swaziland. Journal of Clinical Microbiology, 2014, v. 52(10), p. 3743-3748.

  6. Conway DP, Holt M, McNulty A, et al. Multi-centre evaluation of the Determine HIV Combo assay when used for point of care testing in a high risk clinic-based population. PloS one. 2014, v.  9(4), p. e94062.
  7. WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: ImmunoComb® II HIV 1&2 BiSpot Number: PQDx 0036 -014-00, 24.09. 2014.
  8. Masciotra S, Luo W, Youngpairoj AS, et al. Performance of the Alere Determine HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast. Journal of Clinical Virology: the official publication of the Pan American Society for Clinical Virology, 2013, v. 58S, p.e54-e58.
  9. Faraoni S, Rocchetti A, Gotta F, et al. Evaluation of a rapid antigen and antibody combination test in acute HIV infection. Journal of Clinical Virology: the official publication of the Pan American Society for Clinical Virology. 2013, v. 57(1), p. 84-87.
  10. Laperche S, Leballais L, Ly TD, Plantier JC. Failures in the detection of HIV p24 antigen with the Determine HIV-1/2 Ag/Ab Combo rapid test. The Journal of Infectious Diseases, 2012, v. 206(12), p.1946-1947.
  11. Rosenberg NE, Kamanga G, Phiri S, et al. Detection of acute HIV infection: a field evaluation of the Determine(R) HIV-1/2 Ag/Ab Combo test. The Journal of Infectious Diseases, 2012, v. 205(4), p. 528-534.
  12. Kilembe W, Keeling M, Karita E, et al. Failure of a novel, rapid antigen and antibody combination test to detect antigen-positive HIV infection in African adults with early HIV infection. PloS one,  2012, v. 7(6), p.e37154.
  13. Laperche S et al. Failures in the detection of HIV p24 antigen with Determine® HIV-1/2 Ag/Ab Combo rapid test. Journal of Infectious Diseases, 2012, v.  206(12), p. 1946-1950.
  14. Jones CB et al. Clinical Evaluation of the Determine HIV-1/2 Ag/Ab Combo test. Journal of Infectious Diseases, 2012, v. 206 (12), p.1947–1949.     
  15. Rosenberg NE et al. Point-of-Care Diagnostics for Acute HIV Infection: An Important Public Health Priority. Journal of Infectious Diseases, doi:10.1093/infdis/jis618, 2012.
  16. Naylor E, Axten D, Makia F, Tong C, White J, et al. Fourth generation point of care testing for HIV: validation in an HIV-positive population. Sexually Transmitted Infections, 2011, v. 87(4),  p. 311.
  17. Louie B, et al. Assessment of rapid tests for detection of Human Immunodeficiency Virus-specific antibodies in recently infected individuals. Journal of Clinical Microbiology,   2008, v. 46(4), p.1494-1497.
  18. World Health Organization HIV assays operational characteristics: HIV rapid diagnostic tests (detection of HIV-1/2 antibodies): report 17,  2013.
  19. World Health Organization. HIV Assays: Operational Characteristics Report 16 / Simple/Rapid tests; Geneva: WHO, 2009, Annex 2, p.38.
  20. World Health Organization. Hepatitis B surface antigen assays: operational characteristics: report 1, report 2, 2001, 2004.
  21. S. Masciotra, W.Luo, Ae S. Youngpairoj, M. S. Kennedy, S.Wells, K. Ambrose, P. Sprinkle, S. M.Owen. Performance of the Alere Determine™ HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast. Journal of Clinical Virology  58 (1): 54-58, 2013.
  22. C. Kahlert, S. Daneel, A. Witteck, A. Züst, P. Schmid, J. Thierbach, P. Vernazza and the Swiss. Excellent sensitivity of a rapid 4th generation HIV test (Determine HIV-1/2 Ag/Ab) -based on a blinded evaluation in chronically HIV infected women and men. HIV Cohort Study Cantonal Hospital St. Gallen, Switzerland, Children Hospital St. Gallen, Switzerland, Cantonal Hospital, Transfusion, St. Gallen,  IAS meeting, 2009.
  23. JC Moïsi, SK Saha, AG Falade, BM Njanpop-Lafourcade etl. Enhanced diagnosis of pneumococcal meningitis using the Binax NOW® S. pneumoniae immuno-chromatographic test: a multi-site study. Clin Infect Dis. 48(Suppl 2): S49–S56, 2009.
  24. D.B. Klarkowski, J.M. Wazome, K.M. Lokuge, L.Shanks, C.F. Mills, D.P. O’Brien. The Evaluation of a Rapid In Situ HIV Confirmation Test in a Programme with a High Failure Rate of the WHO HIV Two-Test Diagnostic Algorithm. PLoS ONE 4(2): e4351- 56, 2009
  25. A. Yaaria, D. Tovbinb, M. Zlotnickb, M. Mostoslavskyb, Y. Shemer-Avnia, N. Hanukaa, Z. Burbeac, Z. Katzird, S. Storche and M. Margalithf. Detection of HCV salivary antibodies by a simple and rapid test. Journal of Virological Methods, Vol.133 (1): 1-5, 2006.
  26. A. Yaaria, D. Tovbinb, M. Zlotnickb, M. Mostoslavskyb, Y. Shemer-Avnia, N. Hanukaa, Z. Burbeac, Z. Katzird, S. Storche and M. Margalithf. Detection of HCV salivary antibodies by a simple and rapid test. Journal of Virological Methods, Vol.133 (1): 1-5, 2006.
  27. Anietie E. Moses, Musa A. Garbati, Godwin O. Egwu and James A. Ameh. Detection of E. coli O157 and O26 Serogroups in Human Immunodeficiency Virus-infected Patients with Clinical Manifestation of Diarrhoea in Maiduguri. Journal of Medicine and Medical Sciences, 1(4): 140-145, 2006
  28. Howden BP et al. Chronic falciparum malaria causing massive splenomegaly 9 years after leaving an endemic area. Medical Journal of Australia 2005; 185: 186-188.
  29. A. Loua, F. Bangaly Magassouba, N. Haba, S. Fanta,M. Camara and M. Aliou Baldè, Guinea. Evolution of the seroprevalence of the hiv, the hepatitis b and syphilis with the cnts of conakry of 1997 a 2004. Tansfusion today. 67: 25-26, 2006
  30. B. Rivetz, Z. Kra-Oz, K. Fransen, G. Beelaert, F. Poujade. CDB073 - A multi-center evaluation of the ImmunoComb II HIV 1&2 TriSpot Ag/Ab, a 4th generation simple EIA assay. 4-th Conferens on HIV, Australia, 2007
  31. B Rivetz, E Zemer-Tov, I Russo, A Ben-Zvi and O Faktor. Detection between antibodies to HIV-1 and HIV-2 and p24 antigen. IAS Abstract, 2006.
  32. Ocheng, G; Msuka A. I; Mwizarubi. Evaluation of rapid HIV antibody assays for field use. Is it useful?  National Multisectoral AIDS Conference in Tanzania, 6-10 December 1998.
  33. A.Gautheret-Dejean, S.Mesmin-Poho, Jacques Birguel, V.Lemee, J.-M.Huraux and J.-C.Plantier. Unequal Detection of HIV Type 1 Group O Infection by Simple Rapid Test . Неравноценное определение ВИЧ-1 группы О быстрыми простыми тестами. Clinical Infectious Diseases; 46:1936- 37, 2008.
  34. Offor E., Onakewhor J. U. E., Okonofua. Maternal and neonatal seroprevalence of human immunodeficiency virus antibodies in Benin City, Nigeria. Journal of Obstetrics & Gynaecology,  20 (6): 589-591, 2000.
  35. B.Heartlands, K. Anokye, J.Cook. University Hospital, Middlesbrough, UK. HIV-2 seroprevalence amongst sub-Saharan West African patients attending a public sector clinic in Kumasi/Ghana. British HIV Association, HIV Medicine, 8 (Suppl. 1), 1–82, Oral Abstracts 2007.
  36. Rapport du controle du marche du dispositif medical de diagnostic in vitro : ImmunoComb ® II HIV 1&2 BiSpot (Orgenics Ltd / Inverness). Afssaps- septembre 2006.
  37. S.Bhatt, R.Karnik, R.Bagai, N.Thaker, D.Saha, A.Patel,etl. Comparative evaluation of Rapid and ELISA kits for detection of HIV infection. 2004.A.
  38. Loua, F. B. Magassouba, M. Camara, N. G. Haba & A. M. Balde. Bilan de 4 ans de sérologie VIH au centre national de transfusion sanguine de Conakry. Bull Soc Pathol Exot,  97( 2): 139-141, 2004
  39. D.Bansal, A.K. Patwari, V.L. Malhotra, V.Malhotra and V.K. Anand. Helicobacter pylori infection in recurrent abdominal pain. Indian pediatrics. 35: 329-335 , 1998.
  40. P. Veillon, A. Calvo, F. Lunel-Fabiani. Evaluation of sensitivity and specificity of a new generation of ImmunoComb HCV for the detection of anti-hepatitis C virus antibodies. N° P1645 14th European Congress of Clinical Microbiology and Infectious Diseases, Prague, 2004.
  41. Soroka SD, Grenade TC, Phillips S, and Parekh B. Journal of Clinical Virology 27, pp.90-96, 2003
  42. M.Gisselsson-Sole, A. Bylander, C.Wilhelmsson, A.Hermansson. The Binax NOW Test as a Tool for Diagnosis of Severe Acute Otitis Media and Associated Complications. Journal of clinical microbiology, Vol. 45, No. 9: 3003–3007, 2007.
  43. Koichi Izumikawa, Suguru Akamatsu, Akiko Kageyama, Kiyomi Okada с  Evaluation of a Rapid Immunochromatographic ODK0501 Assay for Detecting Streptococcus pneumoniae Antigen in Sputum Samples from Patients with Lower Respiratory Tract Infection. Clinical and vaccine immunology. Vol. 16, No. 5: 672-678, 2009.
  44. R. Selvarangan, BVSc, PhD, D. Abel, Y. Ballam, BS, K. Nelson, BS, MT(ASCP) and M. Hamilton, MD, PhD. Comparison of BD Directigen™ EZ RSV and Binax NOW® RSV tests for Rapid Detection of Respiratory Syncytial virus from Nasal Aspiratesin a Pediatric Population. Infectious Disease Society of America, 2005.
  45. N.Jonathan. Diagnostic utility of BINAX NOW RSV – an evaluation of the diagnostic performance of BINAX NOW RSV in comparison with cell culture and direct immunofluorescence. Annals of Clinical Microbiology and Antimicrobials, 5:13, 2006.
  46. Lewis J., Moser R., Odongo E.A. Seroprevalince of Clamydia trachomatis in ptegnant ugandan women determined by using a portable elisa system. CDC, Texas, May 1991.
  47. G.Satpathy, A. Sharma & S.Vasisht Immunocomb chlamydia bivalent assay to study Chlamydia speciesspecific antibodies in patients with coronary heart disease. Indian J Med Res 121: 171-175, 2005.
  48. A.Gautheret-Dejean, S. Mesmin-Poho, etl. Unequal Detection of HIV Type 1 Group O Infection by Simple Rapid Test. Clinical Infectious Diseases, 46:1936-7, 2008.
  49. Mounier M., Benabbou L., Sangare A., Gershydamet G.M., Denis F. Sebodiagnostics for Chlamydia trachomatis evaluation by compatison of three methods // Medecine et Malodies Infectieuses. 19 (8/9): 384-387, 1989.
  50. B.M. Branson Journal of Laboratory and Clinical Medicine 27(7/8):288-295, 2003.
  51. G. E. L. van den Berk, P. H. J. Frissen, R. M. Regez, and P. J. G. M. Rietra. Journal of Clinical Microbiology, Vol 41, No.8, pp3868 – 3869, 2003.
  52. Stephen D Lawn, Andrew D Kerkhoff , Monica Vogt, Robin Wood. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 2012; 12: 201–09.
  53. Nteimam Jonathan. Diagnostic utility of BINAX NOW RSV – an evaluation of the diagnostic performance of BINAX NOW RSV in comparison with cell culture and direct immunofluorescence. Annals of Clinical Microbiology and Antimicrobials 2006, 5:13
  54. Mackie P.L, McCormick E.M and Williams C. Evaluation of the Binax NOW RSV as an acute point-of-care screening test in a paediatric accident and emergency unit Communicable Disease and Public Health - Vol 7 No 4 December 2004
  55. Ohm-Smith M.J, Nassos P.S and Haller B.L. Evaluation of the Binax NOW, BD Directigen, and BD Directigen EZ Assays for Detection of Respiritory Syncytial Virus. J Clin Microbiol, Jul 2004, p.2996-2999
85